Indication

Cardioversion of atrial flutter

Cardioversion of atrial flutter refers to the therapeutic termination of atrial flutter to restore normal sinus rhythm within the cardiovascular system. Read more about Cardioversion of atrial flutter

29 drugs 29 manufacturers

Advertisement

Drugs that treat it

Common Cardioversion of atrial flutter therapies.

Showing 19–27 of 29 drugs

DOFETILIDE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+2
SUN PHARMA GLOB

DOFETILIDE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+2
Major Pharamceuticals

QUINIDINE SULFATE

ANTIARRHYTHMIC - CLASS IA·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+3
EPIC PHARMA LLC

DOFETILIDE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+2
DR.REDDY'S LAB

QUINIDINE GLUCONATE

ANTIARRHYTHMIC - CLASS IA·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+3
GSMS, INC.

QUINIDINE GLUCONATE

ANTIARRHYTHMIC - CLASS IA·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+3
EYWA PHARMA INC

DOFETILIDE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+2
NOVADOZ PHARMAC

DOFETILIDE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+2
EXELAN PHARMACE

IBUTILIDE FUMARATE

ANTIARRHYTHMIC - CLASS III·CARDIOVERSION OF ATRIAL FIBRILLATION·+1
Avet Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Cardioversion of atrial flutter preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cardioversion of atrial flutter.

Cardioversion of atrial flutter refers to the therapeutic termination of atrial flutter to restore normal sinus rhythm within the cardiovascular system.

Atrial flutter is a supraventricular tachyarrhythmia characterized pathophysiologically by a rapid, organized macroreentrant circuit—most commonly involving the cavotricuspid isthmus in the right atrium—that drives atrial rates typically between 240 and 350 beats per minute.

Clinically defined on an electrocardiogram by continuous, regular "sawtooth" flutter waves with variable atrioventricular conduction, this dysrhythmia can cause hemodynamic compromise, palpitations, heart failure exacerbations, and an increased risk of thromboembolism.

Conversion back to sinus rhythm is indicated to relieve acute or persistent symptoms and prevent tachycardia-induced cardiomyopathy, accomplished through either synchronized electrical countershock or pharmacological antiarrhythmic therapy.

Personalize your experience

Follow Cardioversion of atrial flutter and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it